Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)
China
· Delayed Price · Currency is CNY 23.96
+0.69 (2.97%)
Apr 29, 2026, 1:05 PM CST
SHE:000766 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 1,170 | 1,169 | 1,322 | 1,470 | 1,470 | 1,514 | Upgrade
|
| Other Revenue | 1.26 | 1.26 | 0.5 | 3.57 | 0.58 | 1.32 | Upgrade
|
| Revenue | 1,171 | 1,170 | 1,323 | 1,473 | 1,471 | 1,515 | Upgrade
|
| Revenue Growth (YoY) | -11.72% | -11.54% | -10.23% | 0.18% | -2.95% | 36.31% | Upgrade
|
| Cost of Revenue | 315.51 | 325.01 | 329.03 | 381.17 | 352.93 | 350.18 | Upgrade
|
| Gross Profit | 855.27 | 844.95 | 993.53 | 1,092 | 1,118 | 1,165 | Upgrade
|
| Selling, General & Admin | 686.21 | 677.13 | 789.26 | 905 | 923.47 | 986.24 | Upgrade
|
| Research & Development | 44.26 | 39.85 | 50.34 | 45.82 | 64.91 | 63.52 | Upgrade
|
| Other Operating Expenses | 14.98 | 14.08 | 9.88 | 10.62 | 11.57 | 5.4 | Upgrade
|
| Operating Expenses | 744.79 | 730.43 | 853.14 | 970.43 | 996.86 | 1,052 | Upgrade
|
| Operating Income | 110.48 | 114.52 | 140.39 | 121.75 | 120.96 | 113.33 | Upgrade
|
| Interest Expense | -82.63 | -81.89 | -84.98 | -83.15 | -88.79 | -97.19 | Upgrade
|
| Interest & Investment Income | 6.74 | 7 | 5.28 | 4.02 | 11.5 | 26.36 | Upgrade
|
| Other Non Operating Income (Expenses) | -4.4 | -4.43 | -2.66 | 1.23 | -3.64 | 3.47 | Upgrade
|
| EBT Excluding Unusual Items | 30.19 | 35.2 | 58.03 | 43.85 | 40.02 | 45.98 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.38 | -0.03 | 0.03 | -2.61 | -0.05 | -0.01 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.05 | -0.05 | -0.17 | -0.21 | -0.02 | 0.83 | Upgrade
|
| Asset Writedown | -0.28 | -0.28 | -0.12 | 0.22 | -0.11 | -1.49 | Upgrade
|
| Other Unusual Items | 8.04 | 7.86 | 9.32 | 13.61 | 10.33 | 14.32 | Upgrade
|
| Pretax Income | 38.29 | 42.71 | 67.09 | 54.86 | 50.17 | 59.62 | Upgrade
|
| Income Tax Expense | 6.53 | 8.51 | 11.11 | 11.63 | 20.99 | 25.64 | Upgrade
|
| Earnings From Continuing Operations | 31.75 | 34.2 | 55.98 | 43.23 | 29.19 | 33.99 | Upgrade
|
| Minority Interest in Earnings | 0.08 | 0.08 | 0.46 | 0.71 | 0.96 | 1.29 | Upgrade
|
| Net Income | 31.83 | 34.29 | 56.44 | 43.93 | 30.15 | 35.27 | Upgrade
|
| Net Income to Common | 31.83 | 34.29 | 56.44 | 43.93 | 30.15 | 35.27 | Upgrade
|
| Net Income Growth | -45.89% | -39.25% | 28.46% | 45.71% | -14.52% | - | Upgrade
|
| Shares Outstanding (Basic) | 859 | 857 | 941 | 879 | 1,005 | 882 | Upgrade
|
| Shares Outstanding (Diluted) | 859 | 857 | 941 | 879 | 1,005 | 882 | Upgrade
|
| Shares Change (YoY) | -8.67% | -8.87% | 7.05% | -12.57% | 13.97% | -9.24% | Upgrade
|
| EPS (Basic) | 0.04 | 0.04 | 0.06 | 0.05 | 0.03 | 0.04 | Upgrade
|
| EPS (Diluted) | 0.04 | 0.04 | 0.06 | 0.05 | 0.03 | 0.04 | Upgrade
|
| EPS Growth | -40.76% | -33.33% | 20.00% | 66.67% | -25.00% | - | Upgrade
|
| Free Cash Flow | 42.3 | 40.99 | 113.58 | 86.11 | 174.42 | 112.85 | Upgrade
|
| Free Cash Flow Per Share | 0.05 | 0.05 | 0.12 | 0.10 | 0.17 | 0.13 | Upgrade
|
| Gross Margin | 73.05% | 72.22% | 75.12% | 74.13% | 76.00% | 76.89% | Upgrade
|
| Operating Margin | 9.44% | 9.79% | 10.62% | 8.26% | 8.22% | 7.48% | Upgrade
|
| Profit Margin | 2.72% | 2.93% | 4.27% | 2.98% | 2.05% | 2.33% | Upgrade
|
| Free Cash Flow Margin | 3.61% | 3.50% | 8.59% | 5.85% | 11.86% | 7.45% | Upgrade
|
| EBITDA | 170.72 | 175.63 | 204.98 | 196.49 | 192.58 | 182.72 | Upgrade
|
| EBITDA Margin | 14.58% | 15.01% | 15.50% | 13.34% | 13.09% | 12.06% | Upgrade
|
| D&A For EBITDA | 60.24 | 61.11 | 64.59 | 74.74 | 71.62 | 69.39 | Upgrade
|
| EBIT | 110.48 | 114.52 | 140.39 | 121.75 | 120.96 | 113.33 | Upgrade
|
| EBIT Margin | 9.44% | 9.79% | 10.62% | 8.26% | 8.22% | 7.48% | Upgrade
|
| Effective Tax Rate | 17.06% | 19.92% | 16.56% | 21.20% | 41.83% | 42.99% | Upgrade
|
| Revenue as Reported | 1,171 | 1,170 | 1,323 | 1,473 | 1,471 | 1,515 | Upgrade
|
| Advertising Expenses | - | 274.54 | 249.73 | 352.83 | 298.68 | 375.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.